Sorrento Therape Stock Today
| SRNE Stock | USD 0 0.0005 16.67% |
Performance4 of 100
| Odds Of DistressOver 82
|
Sorrento Therape is trading at 0.0025 as of the 24th of November 2024, a 16.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0023. Sorrento Therape has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Sorrento Therape are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of September 2024 and ending today, the 24th of November 2024. Click here to learn more.
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. The company was founded in 2006 and is based in San Diego, California. The company has 551.28 M outstanding shares of which 64.56 M shares are at this time shorted by private and institutional investors with about 4.96 trading days to cover. More on Sorrento Therape
Moving against Sorrento OTC Stock
| 0.72 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.72 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.7 | WMT | Walmart Aggressive Push | PairCorr |
| 0.68 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.66 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.65 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sorrento OTC Stock Highlights
| CEO | Henry Ji |
| Business Concentration | NASDAQ Composite Total, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Sorrento Therape [SRNE] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sorrento Therape's market, we take the total number of its shares issued and multiply it by Sorrento Therape's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sorrento Therape conducts business under Biotechnology sector and is part of Health Care industry. The entity has 551.28 M outstanding shares of which 64.56 M shares are at this time shorted by private and institutional investors with about 4.96 trading days to cover.
Sorrento Therape currently holds about 133.6 M in cash with (293.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sorrento Therape Probability Of Bankruptcy
Ownership AllocationSorrento Therape shows a total of 551.28 Million outstanding shares. About 99.17 % of Sorrento Therape outstanding shares are held by general public with 0.8 (%) owned by insiders and only 0.03 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sorrento Ownership Details
Sorrento Therape Risk Profiles
| Mean Deviation | 19.25 | |||
| Semi Deviation | 18.87 | |||
| Standard Deviation | 28.18 | |||
| Variance | 793.9 |
Sorrento Stock Against Markets
Picking the right benchmark for Sorrento Therape otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sorrento Therape otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sorrento Therape is critical whether you are bullish or bearish towards Sorrento Therape at a given time. Please also check how Sorrento Therape's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sorrento Therape without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Sorrento Therape Corporate Management
Elected by the shareholders, the Sorrento Therape's board of directors comprises two types of representatives: Sorrento Therape inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sorrento. The board's role is to monitor Sorrento Therape's management team and ensure that shareholders' interests are well served. Sorrento Therape's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sorrento Therape's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Brunswick | VP Affairs | Profile | |
| Scott Schaus | Chief Officer | Profile | |
| Xiao MD | Pres ACEA | Profile | |
| Robert Allen | VP RD | Profile | |
| Brian Cooley | Sr BU | Profile | |
| Shawn Sahebi | VP Operations | Profile |
Other Information on Investing in Sorrento OTC Stock
Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.